COMMUNIQUÉS West-GlobeNewswire

WePrevent Launches Florida’s First Comprehensive Prevention Health Platform Amid $100B Chronic Disease Crisis
18/08/2025
Miami, Florida , Aug. 18, 2025 (GLOBE NEWSWIRE) -- WePrevent , a Florida-based health innovation company, today announced the launch of WePrevent.org , the state’s first comprehensive online platform connecting [...]
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
18/08/2025
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, announced today its financial results for [...]
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
18/08/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study [...]
Sanofi: Information concerning the total number of voting rights and shares - July 2025
18/08/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2025
18/08/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Attelia Dental Clinic Wins Prestigious Quality Choice Prize 2025 in Stockholm
18/08/2025
Photo: Founder and Chief Dentist Dr. Mehmet İşlek of Attelia Dental Clinic receiving the Quality Choice Prize 2025 award. ANTALYA, Turkey, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Attelia Oral & Dental Health Center , a [...]
Affidea partners with Skin Analytics to improve access to skin cancer assessment across Europe using AI technology
18/08/2025
THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea , a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including oncology, has entered a [...]
Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market
18/08/2025
Smile Group’s investment unlocks new international pathways for Hapbee’s digital wellness platform VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company”) ( [...]
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
18/08/2025
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY ® Cell-Impermeable Endoprosthesis (CIE). The first WRAP North America [...]
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18/08/2025
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare [...]
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
18/08/2025
Live video webcast on Thursday, August 21 st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device [...]
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18/08/2025
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare [...]
Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support
18/08/2025
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch of SmartSupport™, a comprehensive, on-demand virtual support platform designed to enhance the procedural experience for [...]
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
18/08/2025
First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGen Trial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, Aug. 18, 2025 (GLOBE [...]
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
18/08/2025
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“ [...]
Journey Medical Corporation to Present at the Emerging Growth Conference
18/08/2025
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling [...]
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
18/08/2025
August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market Biodexa Pharmaceuticals [...]
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
18/08/2025
ASHBURN, Va., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
18/08/2025
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies [...]

Pages